News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Freeman Mason
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/27/2023 |
4
| Freeman Mason (Chief Medical Officer) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Sold 6 shares
@ $15.21, valued at
$91.3
Unknown transaction of 2,494 shares
@ $0
Disposed/sold 40,000 shares
@ $0
Unknown transaction of 100 shares
@ $0
Disposed/sold 30,178 options to buy
@ $0.92, valued at
$27.8k
Disposed/sold 145,296 options to buy
@ $5.82, valued at
$845.6k
Disposed/sold 120,380 options to buy
@ $7.62, valued at
$917.3k
|
|
| 01/30/2023 |
4
| Freeman Mason (Chief Medical Officer) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Granted 40,000 shares
@ $0 |
|
| 01/13/2022 |
4
| Freeman Mason (EVP Clinical Development) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Bought 2,500 shares
@ $16, valued at
$40k
Bought 100 shares
@ $16, valued at
$1.6k
|
|
| 06/11/2020 |
4
| Freeman Mason (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 6,124 options to buy
@ $7.96, valued at
$48.7k
|
|
| 06/20/2019 |
4
| Freeman Mason (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 6,124 options to buy
@ $3.37, valued at
$20.6k
|
|
| 07/24/2018 |
4
| Freeman Mason (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 12,248 options to buy
@ $4.8, valued at
$58.8k
|
|
|
|